ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2020. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,360 | -54.2% | 13,633 | -35.0% | 0.00% | – |
Q2 2023 | $29,161 | -12.6% | 20,979 | 0.0% | 0.00% | – |
Q1 2023 | $33,357 | -54.4% | 20,979 | +78.7% | 0.00% | – |
Q4 2022 | $73,122 | -14.0% | 11,737 | -7.0% | 0.00% | – |
Q3 2022 | $85,000 | -75.4% | 12,617 | -4.8% | 0.00% | -100.0% |
Q4 2020 | $345,000 | -92.9% | 13,258 | -89.8% | 0.00% | -92.9% |
Q3 2020 | $4,832,000 | -32.0% | 130,006 | -6.2% | 0.01% | -36.4% |
Q2 2020 | $7,110,000 | +113.9% | 138,577 | +31.4% | 0.02% | +83.3% |
Q1 2020 | $3,324,000 | -30.7% | 105,439 | +31.1% | 0.01% | -14.3% |
Q4 2019 | $4,797,000 | +479600.0% | 80,452 | +423331.6% | 0.01% | – |
Q4 2018 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
Q3 2018 | $1,000 | -75.0% | 19 | -81.0% | 0.00% | – |
Q2 2018 | $4,000 | -96.9% | 100 | -94.4% | 0.00% | – |
Q1 2018 | $128,000 | +68.4% | 1,775 | +53.0% | 0.00% | – |
Q4 2017 | $76,000 | +49.0% | 1,160 | +13.7% | 0.00% | – |
Q3 2017 | $51,000 | -58.2% | 1,020 | -80.3% | 0.00% | -100.0% |
Q3 2015 | $122,000 | +3966.7% | 5,182 | +13187.2% | 0.00% | – |
Q2 2015 | $3,000 | – | 39 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 2,679,835 | $69,675,000 | 19.39% |
Endurant Capital Management LP | 207,293 | $5,390,000 | 1.94% |
Bellevue Group AG | 5,138,451 | $133,599,000 | 1.53% |
Rhenman & Partners Asset Management AB | 592,225 | $15,398,000 | 1.26% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,562,869 | $40,635,000 | 0.93% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 31,434 | $817,000 | 0.62% |
WASATCH ADVISORS LP | 3,998,010 | $103,949,000 | 0.51% |
HAMILTON LANE ADVISORS LLC | 46,181 | $1,201,000 | 0.45% |
Boxer Capital, LLC | 500,000 | $13,000,000 | 0.42% |
DCF Advisers, LLC | 38,500 | $1,001,000 | 0.41% |